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http:WHAT THIS PAPER ADDS
The VIRTUE Registry, describes the mid-term clinical and morphological results of thoracic endovascular repair in
patients with type B aortic dissection. Analysis of aortic morphology showed that patients with subacute
dissection demonstrated a similar degree of aortic remodelling to patients with acute dissection. Retention of
aortic plasticity in the subacute group lengthens the therapeutic window for the treatment of uncomplicated
type B dissection.Objective: The VIRTUE Registry describes the mid-term clinical and morphological results of thoracic
endovascular repair (TEVR) in patients with type B aortic dissection.
Methods: This was a prospective cohort study. The VIRTUE Registry is a prospective, multicentre clinical trial that
enrolled patients with complicated acute (<15 days), subacute (15e92 days), and chronic (>92 days) type B
aortic dissections treated with the Valiant endograft. One hundred patients were enrolled and the clinical
outcomes described at the 3-year follow-up. Analysis of the aortic area and false lumen thrombosis rates deﬁned
the morphological response to TEVR in the three clinical groups.
Results: Three-year all-cause mortality (18%, 4%, and 24%), dissection related mortality (12%, 4%, and 9%), aortic
rupture (2%, 0%, and 4%), retrograde type A dissection (5%, 0%, and 0%), and aortic reintervention rates
(20%, 22%, and 39%) were, respectively, deﬁned for patients with acute (n ¼ 50), subacute (n ¼ 24), and chronic
(n ¼ 26) dissections. Analysis of aortic morphology observed that patients with subacute dissection
demonstrated a similar degree of aortic remodelling to patients with acute dissection. Patients with acute and
subacute dissection exhibited greater aortic plasticity than patients with chronic dissection.
Conclusions: The principle clinical ﬁndings suggest that TEVR is able to provide good protection from aortic-
related death in the mid-term, but with a high rate of aortic reintervention. Analysis of aortic morphology
suggested that aortic remodelling in subacute patients is similar to the acute group. Retention of aortic plasticity
in the subacute group lengthens the therapeutic window for the treatment of uncomplicated type B dissection.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 31 December 2013, Accepted 6 May 2014, Available online 18 June 2014
Keywords: Aortic dissection, Endovascular, Type BINTRODUCTION
In recent years, the management algorithm for patients
with type B aortic dissection has changed with the intro-
duction of endovascular repair of the thoracic aorta.1 The
introduction of thoracic endovascular repair (TEVR) for
acute complicated type B aortic dissection has largely been
predicated on early results, which are favourable in com-
parison with open surgery,2 but the mid- and long-term
outcomes remain less well deﬁned.rresponding author. St George’s Vascular Institute, 4th Floor St James
St George’s Hospital, London SW17 0QT, UK. E-mail address: matt.
son@stgeorges.nhs.uk (M. Thompson).
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//dx.doi.org/10.1016/j.ejvs.2014.05.007TEVR has also been advocated as a potential therapeutic
modality in patients with chronic type B aortic dissection.
Although early results have been generally satisfactory, the
mid-term outcomes of TEVR for chronic dissection are
heterogeneous, and it is uncertain whether TEVR can pre-
vent late aortic-related complications or death.3 The un-
certainty over the longer-term clinical outcome in chronic
dissection is partly owing to the differences in aortic
remodelling when acute and chronic aortic dissections are
compared.4 Acute dissections demonstrate rapid expansion
of the true lumen, collapse of the false lumen, and false
lumen thrombosis. These changes are less marked in the
chronic phase, and the lack of false lumen thrombosis may
lead to adverse clinical outcomes.5
The traditional 2-week distinction between the acute and
chronic phases of aortic dissection relate to the timing of
death in the era of open surgery,6 and may not be as useful
364 The VIRTUE Registry Investigatorsin describing the aortic response to endovascular repair.
There has been some suggestion that deﬁning the response
to aortic surgery in a subacute phase (15e92 days) of
dissection might be useful in order to investigate when
the aorta becomes less plastic in its ability to remodel and
whether this has any implications on clinical outcomes.7,8
This study describes the mid-term results of the VIRTUE
Registry. The registry enrolled patients with acute, subacute,
and chronic type B aortic dissections treated with the
Valiant endograft (Medtronic, Santa Rosa, CA, USA). The
early outcomes of this registry have been previously
described,9 and the current report details the later out-
comes with reference to clinical results and aortic
remodelling.METHODS
Study design
The study design has been described in detail previously.9
Brieﬂy, the VIRTUE Registry is a prospective, non-
randomised, multicentre European Clinical Registry that
enrolled 100 patients with type B aortic dissection treated
with the Valiant (Medtronic) thoracic stent-graft.10
Enrolment was performed and consent obtained before
the procedure. The primary endpoint of the registry was
all-cause mortality at 12 months after the procedure.
Secondary endpoints included all-cause and dissection-
related mortality, major complications, reintervention,
and graft-related complications up to 3 years after the
procedure.
Speciﬁc indications for inclusion were documented by the
duration of the disease and were at the clinical discretion of
the investigators:
 acute dissection (14 days from ﬁrst dissection)daortic
rupture, malperfusion syndromes (visceral, renal, lower
limb), impending rupture (persistent pain), refractory
hypertension;
 subacute dissection (15e92 days)dcomplicated/
symptomatic dissection, aortic expansion >5.5 cm,
aortic diameter >4.0 cm with true and false lumens both
patent;
 chronic dissection (>92 days)dcomplicated/symptomatic
dissection, aortic diameter>5.5 cmor expanding>0.5 cm/
year.
Patients were recruited from the centres detailed in
Appendix 1.
As is common in postmarket registries, patient recruit-
ment was not consecutive and there is no information
available concerning how many patients were treated
outside of the registry in the recruiting centres. The
nonconsecutive enrolment is a limitation of this study
with regard to the clinical results reported, but has little
impact on the morphological analysis. The VIRTUE registry
was designed and funded as a 3-year study. The study
closed at 3 years and so longer-term data are not available
for analysis.Analysis of aortic morphology
Patients entered into the registry underwent cross sectional
imaging (computed tomography angiography or magnetic
resonance angiography) preprocedure, prior to discharge,
and at 6, 12, 24, and 36 months postprocedure. Computed
tomography and magnetic resonance imaging were per-
formed according to local protocols and were not stan-
dardized across the study. The cross-sectional imaging was
analysed by a core laboratory (University of Utrecht) to
investigate aortic remodelling. Cross-sectional areas were
determined for the total aorta, the true lumen, and the
false lumen at four reproducible locations (2 cm distal to
the left subclavian artery [LSA], 10 cm distal to the LSA, at
the coeliac axis, and at the largest point of the descending
thoracic aorta [DTA]). The degree of aortic remodelling post-
TEVR was deﬁned as the absolute change in aortic area
(mm2) from the baseline value determined on the pre-
procedure scan.
The rate of complete false lumen thrombosis was site
determined at three locations (ﬁrst half of the DTA [LSA to
carina], second half of the DTA [carina to diaphragm], and
between diaphragm and coeliac axis) at all time points. Data
were presented as cumulative false lumen thrombosis rates
for the three clinical groups. False lumen thrombosis was
assessed by the treating physicians, as this aspect is often
difﬁcult to interpret and there were differing post-
procedural imaging protocols in the study institutions.Statistical analysis
Statistical analysis was performed with SAS version 9.2 (SAS
Institute, Cary, NC, USA). Clinical outcomes and false lumen
thrombosis rates were deﬁned by KaplaneMeier estimated
survival curves, and the differences between the three
clinical groups analysed using the log rank test. Any differ-
ences between the three clinical groups with respect to
aortic remodelling was analysed using repeated measures
analysis of variance with any individual subgroup relation-
ships deﬁned using one-way analysis of variance. Signiﬁ-
cance was assumed at 1:20.
RESULTS
All-cause and dissection-related mortality
The 30-day and in-hospital mortality has been previously
described in detail.9 Brieﬂy, there were six in-hospital
deaths in the cohort with acute complicated type B
dissection, but no early deaths in the patients with sub-
acute or chronic aortic dissection. Two deaths in the acute
cohort were from myocardial ischaemia, one due to para-
plegia and one from ongoing intestinal ischaemia. Two were
dissection related, but no speciﬁc causation was identiﬁed.
The mid-term, all-cause, and dissection-related mortality
are illustrated in Figs. 1 and 2. There was no statistical dif-
ference between the three clinical groups for all-cause
(p ¼ .20) or dissection-related mortality (p ¼ .48).
There were three mid-term deaths in the acute group.
One patient died of a cerebral haemorrhage 251 days after
Figure 1. Freedom from all-cause mortality by clinical group. There was no overall difference in survival between the three groups
(p ¼ .200). Numbers at risk at each time point (days) are tabulated below the ﬁgure. Note. TEVR ¼ thoracic endovascular repair; Post
TEVR ¼ number of patients at risk immediately after TEVR.
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with one patient dying from an acute upper gastrointestinal
bleed due to the formation of an aorto-oesophageal ﬁstula.
The third patient died suddenly out of hospital owing to a
retrograde type A dissection that occurred 65 days after the
endovascular procedure. There was one death in the sub-
acute group due to an extension of the thoracic dissection
to involve the abdominal aorta with development ofFigure 2. Freedom from dissection-related mortality by clinical group. Th
(p ¼ .480). Numbers at risk at each time point (days) are tabulated b
TEVR ¼ number of patients at risk immediately after TEVR.visceral malperfusion. Interventional therapy was not
possible and the patient died 84 days after the original
surgery. There were six deaths in the chronic group, two
from cardiac causes, two from respiratory causes, and one
each from gastrointestinal ischaemia and pancreatic cancer.
With regard to neurological complications, there was one
mid-term cerebellar stroke in the acute group at 2 years.
The patient originally had TEVR for a ruptured dissectionere was no overall difference in survival between the three groups
elow the ﬁgure. Note. TEVR ¼ thoracic endovascular repair; Post
366 The VIRTUE Registry Investigatorswith partial LSA coverage and no LSA revascularisation.
There was one episode of transient spinal cord ischaemia in
a patient originally treated for a chronic aortic dissection
that occurred 1 year after the index operation.
Aortic related reinterventions, endoleak, aortic rupture,
and retrograde type A dissection
The freedom from aortic-related interventions is illustrated
in Fig. 3 and the nature of the most common interventions
is given in Table 1. Although there was no signiﬁcant dif-
ference in the three patient groups with respect to overall
aortic reintervention (p ¼ .19), the need for additional
thoracic endografts was greater in the patients with chronic
dissection, with >30% of these patients requiring further
TEVR. In the majority of cases, the additional endografts
were required for distal aneurysmal degeneration of the
chronic dissection below the primary endografts.
In total, there were four proximal type 1 endoleaks re-
ported that required intervention. Two patients originally
treated for subacute dissections required proximal endog-
rafts (one needing arch debranching). Similarly, two patients
with chronic dissections needed revisional surgery for
proximal endoleak, one requiring TEVR and the other sur-
gical conversion. One patient required intervention for a
type III endoleak. Seven patients with chronic dissection
required distal extension owing to a distal type 1 endoleak
or persistent perfusion of the false lumen with aortic
expansion.
There were two cases of aortic rupture in the study.
There was one early rupture in a patient with an acute
dissection and one rupture in the mid-term due to persis-
tent perfusion of the false lumen in a patient treated for aFigure 3. Freedom from aortic-related reinterventions by clinical grou
three groups (p ¼ .190). Numbers at risk at each time point (days) ar
repair; Post TEVR ¼ number of patients at risk immediately after TEVchronic dissection. The latter patient was successfully
treated by distal endograft placement.
There were no cases of retrograde type A dissection
(RTAD) in the subacute or chronic groups. There were two
patients with RTAD in the acute group. One patient had a
fatal event on day 65 and has been described above. The
other patient developed chest pain 20 months after the
index procedure and was diagnosed with RTAD and aortic
valve regurgitation. Surgical repair was undertaken with a
good clinical result.
Aortic morphology after TEVR
The luminal areas were deﬁned for three anatomical aortic
locations, 2 cm distal to the LSA, 10 cm distal to the LSA,
and at the level of the coeliac axis. The luminal areas were
also analysed at the point of maximum thoracic aortic
diameter. The mean change in true lumen and false lumen
area compared with preprocedural imaging is illustrated in
Figs. 4 and 5 for the three clinical groups, at 10 cm distal to
the LSA. Changes for all aortic locations are illustrated in the
Supplementary Figs. S1 and S2.
Analysis of true lumen change demonstrated that, across
all three clinical groups, the true lumen area increased after
TEVR at all anatomic locations, and that the extent of true
lumen expansion increased with time (p < .001). There was
no signiﬁcant difference between the three clinical groups
with regard to the expansion of the true lumen after TEVR.
The majority of the aortic remodelling was complete within
6 months of TEVR.
The change in false lumen area was more heterogenous
across the three clinical groups. At all three anatomical lo-
cations, the false lumen area decreased in the acute andp. There was no overall difference in reintervention between the
e tabulated below the ﬁgure. Note. TEVR ¼ thoracic endovascular
R.
Table 1. The most common aortic reinterventions required in the








TEVR extension 4 (8%) 4 (17%) 8 (31%)
Open AAA repair 2 (4%) 0 0
Reballooning of graft 1 (2%) 0 1 (4%)
LSA embolisation 1 (2%) 1 (4%) 0
Note. TEVR ¼ thoracic endovascular repair; AAA, abdominal aortic
aneurysm; LSA ¼ left subclavian artery.
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reduction being signiﬁcantly greater with time after TEVR
(p < .001). In contrast, the false lumen area change was less
consistent in the patients with chronic dissection, with both
reduction in false lumen area and an increase in false lumen
area being observed at different time points and different
locations. At all three anatomical locations there was a
signiﬁcant difference in false lumen area change between
the clinical groups (p < .001, p < .001, p < .001 for
anatomic locations 2 cm distal LSA, and 10 cm distal LSA
and coeliac axis, respectively), with the acute and subacute
group demonstrating a greater reduction in false lumen
area than the chronic clinical group. The differences be-
tween the clinical groups in terms of false lumen remod-
elling are illustrated by the analysis of the aorta at the
largest point. This analysis demonstrated that the acute and
subacute clinical groups demonstrated a reduction in false
lumen area at all time points, which is in contrast to the
chronic group where an overall increase in false lumen area
was observed. There was a signiﬁcant difference in false
lumen area change between the acute and chronic groupFigure 4. Change in true lumen area plotted for the three clinical gro
change in true lumen area from baseline preoperative scans at 10 cm
point (months) are tabulated below the ﬁgure. Note. TEVR ¼ thorac
immediately after TEVR.(p < .001) and the subacute and chronic groups (p ¼ .004).
There was no difference in false lumen area change be-
tween the acute and subacute groups.
The cumulative occurrence of false lumen thrombosis in
the three clinical groups is illustrated in Figs. 6 and 7 for two
anatomical regions (distal half of the DTA and between
diaphragm and coeliac axis). The cumulative occurrence of
false lumen thrombosis increased with time after TEVR, and
was greater the more proximal the anatomical location.
There was no difference in false lumen thrombosis rates
between the three clinical groups in the proximal (p ¼ .330)
and distal DTA (p ¼ .520). Analysis of false lumen throm-
bosis rates between the diaphragm and coeliac axis
demonstrated that patients with chronic dissection had
signiﬁcantly lower false lumen thrombosis than patients
with subacute or acute dissection (p ¼ .035).DISCUSSION
Patients with type B aortic dissection form a heterogenous
group with regard to endovascular intervention. Endovas-
cular repair of the thoracic aorta has been enthusiastically
adopted for treatment of acute complicated type B
dissection, and this technique has now been used for more
chronic lesions. The indications for intervention in acute and
chronic type B aortic dissections differ considerably and the
aim of therapy often differs, with treatment in the acute
group concentrating on relief of life threatening complica-
tions, whereas therapy in the chronic group must focus on
the long-term prevention of aortic-related death. Given the
inherent heterogenicity of the aortic pathology, outcome
data must be stratiﬁed by the temporal classiﬁcation of theups over the course of the study. The data are given as the mean
distal to the left subclavian artery. Numbers analysed at each time
ic endovascular repair; Post TEVR ¼ number of patients at risk
Figure 5. Change in false lumen area plotted for the three clinical groups over the course of the study. The data are given as the mean
change in true lumen area from baseline preoperative scans at 10 cm distal to the left subclavian artery. Numbers analysed at each time
point (months) are tabulated below the ﬁgure. Note. TEVR ¼ thoracic endovascular repair; Post TEVR ¼ number of patients at risk
immediately after TEVR.
368 The VIRTUE Registry Investigatorsdissection. The present study reports the mid-term clinical
outcomes and aortic morphology after TEVR for acute,
subacute, and chronic aortic dissection.
The early clinical results from the VIRTUE Registry have
been reported previously,9 and demonstrated a 12%
decrease in hospital mortality in the acute group, with noFigure 6. Cumulative incidence of false lumen thrombosis plotted for th
aorta. Numbers analysed at each time point (days) are tabulated be
TEVR ¼ number of patients at risk immediately after TEVR.deaths in the patients with subacute or chronic dissections.
Analysis of the mid-term results in the present study
demonstrated that patients in the acute and subacute
group had relatively low all-cause mortality following the
index admission. In contrast, patients with chronic dissec-
tion appeared to show an increased (although none three clinical groups in the distal half of the descending thoracic
low the ﬁgure. Note. TEVR ¼ thoracic endovascular repair; Post
Figure 7. Cumulative incidence of false lumen thrombosis plotted for the three clinical groups at the level of the coeliac axis. Numbers
analysed at each time point (days) are tabulated below the ﬁgure. Note. TEVR ¼ thoracic endovascular repair; Post TEVR ¼ number of
patients at risk immediately after TEVR.
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pathology. Analysis of patient demographics did not reveal
any obvious explanation for this appearance, with similar
risk factors reported in all three groups.
While there are numerous reports of the early clinical
outcomes of TEVR for aortic dissection, the mid- and long-
term outcomes are more sparsely described. In particular,
it will be important to ascertain whether endovascular
techniques offer the same degree of protection from late
aortic-related mortality that is described for open surgical
repair, although the results from open surgery are incon-
sistent.11,12 In the present study, life table analysis
demonstrated low rates of dissection-related mortality in
the mid-term, which is concordant with other studies.13,14
There was no difference in mid-term clinical outcomes
between the three clinical groups, although the small size of
the groups makes this analysis subject to potential error.
The dissection-related deaths that occurred were due to
RTAD, development of an aorto-oesophageal ﬁstula, and an
extension of previous dissection. In all, there were two
cases of RTAD, both in patients with acute dissections.
There were no cases of RTAD in the subacute or chronic
group, which supports previous observations that RTAD
may be associated with the fragile aortic intima in the acute
setting.15,16 The lack of RTAD in this study is encouraging
given that the endograft used in the study would, today, be
regarded as an early design without tip capture.
The present study reported a very low rate of aortic
rupture in the mid-term, which is similar to previous pub-
lications and suggests reasonable mid-term outcomes.17However, the protection from aortic-related death comes
at a price of a high reintervention rate in all three groups.
The reintervention rate in the present study was similar to
that described in previous work,18 and remains a cause of
concern. In particular, there was a high requirement (seven
of 26) for a distal extension to the primary endograft in
patients with chronic dissection. This may be related to the
poor aortic remodelling observed in patients with chronic
dissection who subsequently developed distal aneurysmal
degeneration below the primary endograft. The length of
aorta covered by the endograft in the acute, subacute, and
chronic groups was, respectively, 151, 166, and 164 mm,
which suggests a similar operative strategy in all three
clinical groups with regard to the extent of aortic coverage.
The clinical data revealed in the present study suggest that
limited coverage of the DTA in patients with chronic
dissection leads to a high requirement for later distal
extension. Given the lack of aortic remodelling in patients
with chronic dissection and the requirement to achieve
false lumen thrombosis, these data suggest that extensive
aortic coverage should be considered in the primary pro-
cedure. More extensive aortic coverage in chronic dissec-
tions would also be supported by recent data that
demonstrate that false lumen thrombosis is not reliably
achieved below the level of the stent,19 and that complete
false lumen thrombosis leads to better clinical outcome.5
Extending the length of coverage has theoretical risks in
increasing paraplegia rates and so further data will be
required to clarify this risk, especially as spinal ischaemia
may be mitigated by continued false lumen perfusion.
370 The VIRTUE Registry InvestigatorsPatients treated for chronic dissection generally have lower
spinal cord ischaemia rates than those treated for degen-
erative aneurysms.17
A unique aspect of the present study was that dissections
were classiﬁed into three temporal clinical groups, and
included a cohort of patients with subacute dissections. This
allowed remodelling of the aorta, in response to TEVR, to be
deﬁned for different temporal classiﬁcations, in contrast to
the traditional acute and chronic groups. The traditional
classiﬁcation has some limitations when deﬁning aortic
remodelling as the chronic group contains dissections from
2 weeks to many years in existence. The present study
conﬁrmed previous ﬁndings that aortic remodelling (true
lumen expansion and false lumen regression) after TEVR is a
continuous process,20 that acute dissections remodel more
rapidly than chronic dissections,21 and that remodelling is
greater in more proximal aortic segments.4
A signiﬁcant ﬁnding from the present study was that
patients with subacute dissections showed aortic remod-
elling that was analogous to the acute group rather than the
patients with chronic dissection. Patients in the subacute
cohort demonstrated signiﬁcantly greater false lumen area
regression than patients with chronic dissection, while
there was no difference between false lumen regression in
the subacute and acute group. These ﬁndings are important
and suggest that the aorta retains its plasticity to remodel in
response to TEVR for at least 92 days after the index
dissection.
In addition to changes in true lumen and false lumen
area, aortic remodelling after TEVR aims to initiate com-
plete false lumen thrombosis, which is an indicator of
clinical success,22 and may inﬂuence long-term outcome.5
The present study conﬁrmed that false lumen thrombosis
is a continuous process, with a higher rate in the proximal
aorta. The present study observed that the extent of false
lumen thrombosis at the diaphragm was greater in the
acute and subacute groups than in patients with chronic
dissection. Again, this suggests similar aortic remodelling
after TEVR in the acute and subacute groups. Interestingly,
the timing of false lumen thrombosis appeared different to
that of the aortic remodelling. While much of the aortic
remodelling was complete at 1 year, false lumen thrombosis
rates at the diaphragm continued rising to 3 years. The
explanation for this is unclear, but has been reported in
previous studies.4
The aortic plasticity exhibited by the subacute group has
relevance when considering therapy for patients who pre-
sent with uncomplicated acute dissection. The INSTEAD trial
has demonstrated a late survival beneﬁt for patients with
uncomplicated chronic dissection treated with TEVR as
compared with standard medical management.23,24 This
survival beneﬁt appeared to be associated with a high rate
of false lumen thrombosis and aortic remodelling; inter-
estingly, the majority of patients in this trial were rando-
mised in the early chronic phase of dissection.25 Given the
low rate of complications for the endovascular treatment of
patients with subacute dissection reported in the present
study and elsewhere,8 the aortic plasticity observed in thisphase of the disease opens a potentially attractive thera-
peutic window. Further clinical data are required to deﬁne
exactly which groups of patients with uncomplicated
dissection require intervention.
The present study has some limitations with regard to
the analysis of aortic morphology and clinical outcomes. The
clinical groups are insufﬁciently large to allow detailed
analysis of the factors, aside from the deﬁned clinical
groups, that predispose to remodelling and false lumen
thrombosis. In particular, detailed information regarding the
exact location of primary and secondary tears is not avail-
able. The clinical outcomes may have been affected and
potentially biased, as the patients in the registry were not
enrolled consecutively.
The VIRTUE study has provided detailed clinical and
morphological data regarding endovascular treatment of
type B aortic dissection. The principle clinical ﬁndings sug-
gest that TEVR is able to provide good protection from
aortic-related death in the mid-term, but with a high rate of
aortic reintervention. The present study has identiﬁed that
technical reﬁnements to the operative procedure might be
able to reduce the rate of reintervention in the chronic
groups with greater aortic coverage in the primary proce-
dure. Analysis of aortic morphology has suggested that
aortic remodelling in the subacute patients is similar to the
acute group. Retention of aortic plasticity in the subacute
group lengthens the therapeutic window for the treatment
of uncomplicated type B dissection.
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INVESTIGATORS WITH LEAD INVESTIGATOR AND NUMBER
OF PATIENTS RECRUITED
St. Antonius Ziekenhuis, Nieuwegein (R. Heijmen, 20 pa-
tients); Ospedale Sant’Orsola Malpighi, Bologna (R. Fattori,
19 patients); St George’s Vascular Institute (M. Thompson,
16 patients); Universitätsspital Bern, Inselspital (Dai-Do D.,
nine patients); Universitätsklinikum Essen (H. Eggebrecht,
seven patients); Onze-Lieve-Vrouw Ziekenhuis, Aalst (I.
Degrieck, seven patients); University School of Medicine
Rostock (C. Nienaber, six patients); St Mary’s Hospital Lon-
don (N. Cheshire, ﬁve patients); Unità di Chirurgia Vasc,
Ospedale R. Silvestrini, Perugia (P. Cao, three patients);
Heart Centre Freiburg University (B. Rylski, two patients);
Sahlgrenska University Hospital, Gothenburg (H. Roos, two
patients); Azienda Osp “Santa Maria della Misericordia”,
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versitario San Cecilio, Granada (E. Ros Die, one patient);
Hospital Universitario La Paz, Madrid (G. Garzon, one pa-
tient); Medtronic Clinical Trials (S. Kam, S. Deckers, R.
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